Top News

  • Cook Regentec announces collaboration with IU School of Medicine

    Cook Regentec, Cook Group’s first company in Indianapolis, cut the ribbon yesterday on its new facility on Indiana Avenue and announced a collaboration with Indiana University School of Medicine aimed at developing tools and technologies that advance solutions in the emerging areas of immunotherapy, precision medicine, drug delivery, regenerative medicine and bioprinting.

    Cook Regentec develops and commercializes research and clinical tools to advance regenerative medicine therapies. The company celebrated the completion of the transformation and rehabilitation of a former beer warehouse into a 22,000-square-foot innovation center with modern, collaborative office space and adjacent advanced laboratory facilities. 

    Founded in 2015 as an incubator/accelerator for biological and device innovations, Cook Regentec has created three early-stage companies that have already commercialized 12 different products, including cellular growth media, solutions for cryopreservation and medical devices for the delivery of therapeutic agents.

    The relationship with IU School of Medicine delivers on Cook Regentec’s mission to leverage the Indianapolis life sciences and advanced industry ecosystem to continue developing and commercializing new technologies across industries and disciplines. Cook Regentec scientists, engineers and product developers will connect with IU School of Medicine researchers and scientists at The Collaboratory @ Cook Regentec. The new collaboration space is a 6,000-square-foot idea lab and collaborative technology incubator located at Cook Regentec’s newly rehabilitated Indianapolis headquarters.

    “As a medical school, we are driven to develop new therapies for patients who are affected by devastating and life-threatening illnesses and injuries,” said Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and IU’s executive vice president for university clinical affairs. “This exciting new opportunity will enable us to tap into Cook Regentec’s extraordinary expertise to ensure those discoveries are commercially viable and can be delivered to patients as efficiently as possible.”

    Learn more in IU School of Medicine Regentec announcement news release.

    Back to Top ▲

  • U.S. Senator Todd Young tours breast cancer research lab

    U.S. Senator Todd Young visited IU School of Medicine on Friday, October 19, to meet with IU Simon Cancer Center researchers and learn about the global impact of the center’s research. The visit included a tour of a breast cancer research laboratory and discussion with IU Simon Cancer Center Director Patrick J. Loehrer, MD. Loehrer briefed Senator Young about how the center’s National Institutes of Health investments in IU research are improving patient outcomes and contributing to the state’s economy.

    “There’s a broad recognition in central Indiana that the IU Simon Cancer Center is doing outstanding world-class research,” said Senator Young. “I wanted to understand in a more detailed way what sort of projects are ongoing and how I might be helpful in moving forward in ensuring that this center has the requisite resources to continue its good work and perhaps even expand into other areas that can help save lives and ensure Hoosiers have access to outstanding medical care.”


    Back to Top ▲

  • Emeritus professor Miyamoto awarded IU President’s Medal

    Richard Miyamoto, MD, the Arilla Spence DeVault Professor Emeritus of Otolaryngology, has received the highest honor an Indiana University president can bestow—the President’s Medal for Excellence.

    Miyamoto is internationally recognized as a pioneer in the field of cochlear implantation in children and adults. Soon after becoming a faculty member at IU in 1978, Miyamoto worked with Dr. William House, the creator of the modern cochlear implant and known as the "Father of Neurotology," to establish the first clinical trial in the United States of the implants, which are small electronic devices that restore the ability to perceive sounds in those who are born deaf.

    As the only co-investigator affiliated with an academic medical center, Miyamoto was instrumental in getting cochlear implants approved by the U.S. Food and Drug Administration. He also led the charge to make cochlear implants available to children of younger and younger ages, allowing them to hear in the critical first months and years of life when their brains are developing speech and language skills.

    Miyamoto received the medal at the 12th annual Academic Excellence Dinner on Wednesday, October 17. IU Distinguished Professor Emeritus of Fine Arts Rudy Pozzatti and IU Professor Emerita of Earth and Atmospheric Sciences Lisa Pratt also earned the high honor.


    Back to Top ▲

  • School accepting nominations for Watanabe Translational Research Prize

    Applications are now being accepted for the 2019 August M. Watanabe Prize in Translational Research, awarded to an investigator who has made a significant contribution to the field of translational science.

    The Watanabe Prize is one of the nation’s largest and most prestigious awards recognizing individuals focused on shepherding scientific discoveries into new therapies for patients. It is named in honor of the late August M. Watanabe, a titan in the field of translational research in both academia and industry, who impacted the health of people around the world as a leader at IU and Eli Lilly and Co.

    Nominees for the Watanabe Prize should be members of the scientific or medical community who have achieved outstanding accomplishments in translational research. This award is conferred upon senior investigators whose influential research deserves major recognition.

    The winner of the 2019 Watanabe Prize will receive a $100,000 award and spend time in Indianapolis as a visiting dignitary to share knowledge with audiences at IU and partner institutions. Over the next two years, the honoree also will serve as a long-distance mentor to two exceptional young investigators named concurrently as Watanabe Translational Scholars.

    Nomination deadline is Monday, January 28, 2019. Submission details and requirements are available. Email or call 317.278.2874 with questions.


    Back to Top ▲

  • New York Times column: Carroll weighs in on Apple watch’s new EKG feature

    The newest Apple watch will include an electrocardiography (EKG) feature as part of its heart monitor app, causing consumers to believe it’s a new leap forward in improving health. But is it really? IU School of Medicine professor of pediatrics Aaron Carroll, MD, explains the pros and cons of the new feature in this New York Times column.

    Back to Top ▲

Faculty and Staff News

  • IU open enrollment begins November 5

    Indiana University’s open enrollment is November 5-16. During this time, IU employees can make changes to their medical and dental insurance, add or remove eligible dependents, determine their use and savings needs for their Health Savings Account contribution and more. This year, eligible employees also have a one-time opportunity to enroll in or increase their level of coverage in Long-Term Disability Insurance without providing proof of good health. Information booklets begin arriving in campus mail this week, and additional information is available from Human Resources. News at IU offers more details on what’s new in open enrollment this year.

    Back to Top ▲

  • Review IU’s policy on paid time off to vote

    Making plans to vote on November 6? Indiana University policy allows paid time off for staff employees (up to a maximum of two hours) whose work schedules prevent them from voting between 6 am and 6 pm. (See this article for examples of when paid time off is allowed.)

    In addition, IU has developed guidelines for political campaigns, invitations, events and activities to clarify the types of activities that are permitted and those that are restricted. Full policy details related to political activities are available.

    Questions about the IU policies? Contact Human Resources.

    Back to Top ▲

  • networkIN to host November 13 event for postdocs, graduate students

    Postdoctoral and graduate students are invited to attend a networking event from 6-8 pm, Tuesday, November 13, at Daredevil Brewing Company, 1151 Main St., in Indianapolis. Take advantage of the opportunity to meet and network with peers, graduate students and representatives from the biomedical and life sciences companies in central Indiana. Register for the event by Monday, November 12.

    Back to Top ▲


  • Don Brown, MD, to deliver keynote address at business of health care conference

    IU School of Medicine alumnus and donor Don Brown, MD, will deliver the keynote address for the “The Changing Business of Healthcare” conference, presented by the IU Kelley School of Business, on Friday, November 9, at Roche Diagnostics corporate headquarters in Indianapolis. Brown’s presentation is titled “Better Late Than Never: Technology Is Finally Poised to Disrupt Healthcare.” Registration and additional information are available.

    Brown gifted $30 million to the school in December 2017 to establish the Brown Center for Immunotherapy, which aims to develop new treatments and cure disease through the use of cell-based immunotherapies.

    Back to Top ▲

  • Next Culture and Conversation event is November 8

    Culture and Conversation (C&C) is a monthly discussion series focused on issues related to representational diversity, inclusive working and learning environments, and cultural competence. The next event, “TED Talking – (Re)Making History: The Real Story is Bigger and Better” will be held on Thursday, November 8. Registration is available. C&C is sponsored by IU School of Medicine Faculty Affairs, Professional Development and Diversity.

    Back to Top ▲

  • Apply for Indiana CTSI predoctoral, postdoctoral training awards

    The Indiana Clinical and Translational Sciences Institute (CTSI) is offering special predoctoral and postdoctoral training awards in translational research. Translational research refers to what is commonly termed "bench to bedside," the process by which research in the lab "translates" into patient treatment. Translation may involve applying discoveries made during research (in the lab, through animal studies, etc.) to the development of clinical trials and studies in humans, or carrying out research aimed at enhancing the adoption of best practices, or both.

    View eligibility and award information for predoctoral training awards.
    View eligibility and award information or postdoctoral training awards.

    Application deadlines are Thursday, November 15, for the predoctoral award and Monday, December 3, for the postdoctoral awards.

    Back to Top ▲

  • GLUE funding available for collaborative research teams

    Grants Linking University–wide Expertise (GLUE) awards support planning and team building across campuses to develop large multi-investigator and/or multi-project translational research teams. Eligible teams are those planning to eventually submit multi-year extramural grant applications with annual budgets of $300,000 or higher in direct costs. Examples of such grants include PPGs, U series, multi PI R01s, STTRs and SPORE grants. 

    Applications for GLUE grants are accepted for review at any stage of their development. It is expected that these planning/seed grants will increase multidisciplinary collaborations, institutional competitiveness, opportunities for extramurally funded training grants and overall institutional funding. GLUE funding is available to collaborative teams where the lead principal investigator is from Indiana University Bloomington and other members of the team are from Indiana CTSI-affiliate campuses. Submission deadline is Monday, January 28.

    Back to Top ▲

Partner News

  • IU Health “vital patient record rules” go into effect November 1

    Did you know that accessing your own medical record or viewing the medical record of someone you know without an authorized need is one of the most common violations of patient privacy?

    This type of activity—referred to as “self, friends and family” access—can harm the authenticity of important patient information and interfere with your ability, or the ability of your friend or family member, to receive the best care. Even if you’re acting with the best intentions, using Cerner, Epic, PACS or any kind of electronic medical record (EMR) system to view patient information without an authorized need is a violation of HIPAA laws and must be reported.

    On Thursday, November 1, the IU Health Privacy Office will activate a new security feature to detect this type of activity. This new feature is a part of Haystack—a tool launched in February 2018 as an added safeguard to help keep patient information confidential and secure through tracking EMR activity. If Haystack flags out-of-ordinary behaviors based on team members’ previous activities, job codes and other factors, the Privacy Office is alerted to investigate.

    Refer to MEDNet for more details and information about patient privacy.

    Back to Top ▲


  • Allen named outstanding Texas A&M University alumnus

    Matthew Allen, PhD, assistant dean for faculty affairs and professional development, will receive an outstanding alumni award from his alma mater, Texas A&M University, in a ceremony this week on the university’s campus in College Station, Texas. Allen earned his doctoral degree from Texas A&M in 2003.

    Back to Top ▲